Over 35 outstanding presentation/panel discussions
4 interactive streams:
• Translational Biomarkers for Safer Drugs
• PK/PD Value and Strategies
• Improving Global Drug Development: Regulation Guidelines, Risk Management and CRO Selection
• Modeling Methods – Early Toxicity Risk Discharge
14 pre-scheduled one to one business meetings & exhibition
Co-located with the 13th Annual Drug Discovery Leaders Summit
Oxford Global Conferences are pleased to announce the 4th Annual Drug Development Leaders Summit being held in June 2012 in Switzerland. The event offers over 250 attendees a valuable opportunity to network with senior-level decision-makers from leading pharmaceutical, biotech companies, clinical research institutions, academic and healthcare institutions working throughout the Drug Discovery & Development Value Chain.
The Pharmaceutical Industry is facing rising clinical development costs and falling drug discovery success rates. In order to stay competitive, they are re-evaluating their drug development processes and working to reduce late phase attrition rates. The industry is investing more in safety and research measures than ever before and combined with an ever-changing framework of regulation the path the market has never been more complicated or costly for key practitioners in Drug Development. There is an urgent need for improved phase processes, Partnering and Outsourcing strategies and Novel Technologies that will enable the delivery of improved drugs to market quicker and ultimately the establishment of a more robust and lean pipeline.
Do not miss out on our co-located the 13th Drug Discovery Leaders Summit, which provides a first class educational and networking opportunity for attendees to gain knowledge and insights into the entire Drug Discovery marketplace.
Further Conference Details
